{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:41:10Z","timestamp":1791945670669,"version":"4.3.4"},"reference-count":181,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jprot.2010.11.010","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T09:23:21Z","timestamp":1290763401000},"page":"371-388","source":"Crossref","is-referenced-by-count":129,"title":["Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics"],"prefix":"10.1016","volume":"74","author":[{"given":"A.C.","family":"Kroksveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Opsahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.T.","family":"Aye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Ulvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Berven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2010.11.010_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4615-4871-3_6","article-title":"Vasopressin gene expression in rat choroid plexus","volume":"449","author":"Chodobski","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0010","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.1999.276.1.C82","article-title":"AVP V1 receptor-mediated decrease in Cl\u2212 efflux and increase in dark cell number in choroid plexus epithelium","volume":"276","author":"Johanson","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF00711896","article-title":"Extracellular and cerebrospinal fluids","volume":"16","author":"Segal","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.2000.7545","article-title":"Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?","volume":"167","author":"Stopa","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3171\/jns.1983.59.3.0369","article-title":"Recent research into the nature of cerebrospinal fluid formation and absorption","volume":"59","author":"McComb","year":"1983","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jprot.2010.11.010_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican1189-68","article-title":"The mammalian choroid plexus","volume":"261","author":"Spector","year":"1989","journal-title":"Sci Am"},{"key":"10.1016\/j.jprot.2010.11.010_bb0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/epr.10.6","article-title":"Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers","volume":"7","author":"Suk","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainresrev.2010.04.006","article-title":"The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations","volume":"64","author":"Oreskovic","year":"2010","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.jprot.2010.11.010_bb0045","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.addr.2004.07.008","article-title":"Peptide and peptide analog transport systems at the blood-CSF barrier","volume":"56","author":"Smith","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jprot.2010.11.010_bb0050","series-title":"Neuroimmune Pharmacology: Springer Science Business Media LLC","author":"Przedborski","year":"2008"},{"key":"10.1016\/j.jprot.2010.11.010_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchromb.2008.05.001","article-title":"The human cerebrospinal fluid metabolome","volume":"871","author":"Wishart","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood\u2013brain barrier: Development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-004-0928-x","article-title":"Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact","volume":"109","author":"Wolburg","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0736-4679(01)00360-2","article-title":"Cerebrospinal fluid","volume":"21","author":"Jerrard","year":"2001","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jprot.2010.11.010_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jprot.2010.11.010_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clineuro.2008.12.004","article-title":"A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting","volume":"111","author":"Regeniter","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jprot.2010.11.010_bb0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","article-title":"Protein biomarker discovery and validation: the long and uncertain path to clinical utility","volume":"24","author":"Rifai","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0095","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/mcp.R800015-MCP200","article-title":"A human proteome detection and quantitation project","volume":"8","author":"Anderson","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4161\/cbt.8.12.8634","article-title":"The evolving role of mass spectrometry in cancer biomarker discovery","volume":"8","author":"Wang","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jprot.2010.11.010_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow-rate of cerebrospinal-fluid (Csf)\u2014a concept common to normal blood\u2013Csf barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/prca.200700081","article-title":"Proteomics of human cerebrospinal fluid\u2014the good, the bad, and the ugly","volume":"1","author":"Zhang","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2010.11.010_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/1522-2683(200204)23:7\/8<1185::AID-ELPS1185>3.0.CO;2-G","article-title":"Analysis of the human lumbar cerebrospinal fluid proteome","volume":"23","author":"Yuan","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0120","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.000877","article-title":"Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples","author":"Stoop","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1383\/medc.32.9.44.49909","article-title":"Lumbar puncture and CSF examination","volume":"32","author":"Sharief","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.jprot.2010.11.010_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000116919","article-title":"Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18\u201388 years of age","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0135","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3","article-title":"Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis","volume":"21","author":"Sickmann","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1570-0232(01)00626-2","article-title":"Towards a high resolution separation of human cerebrospinal fluid","volume":"771","author":"Sickmann","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0145","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/elps.200406012","article-title":"Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual","volume":"25","author":"Finehout","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/pmic.200400934","article-title":"Proteomics analysis of prefractionated human lumbar cerebrospinal fluid","volume":"5","author":"Yuan","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0155","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/elps.200305909","article-title":"Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry","volume":"25","author":"Maccarrone","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/pr025526s","article-title":"Rapid analysis of tryptically digested cerebrospinal fluid using capillary electrophoresis-electrospray ionization-Fourier transform ion cyclotron resonance-mass spectrometry","volume":"1","author":"Wetterhall","year":"2002","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jms.737","article-title":"Human cerebrospinal fluid peptidomics","volume":"40","author":"Yuan","year":"2005","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.jprot.2010.11.010_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/pr034070r","article-title":"Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS\/MS","volume":"3","author":"Wenner","year":"2004","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2004.03.012","article-title":"Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid","volume":"26","author":"Zhang","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jprot.2010.11.010_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0074-7742(06)73002-1","article-title":"Characterization of proteome of human cerebrospinal fluid","volume":"73","author":"Xu","year":"2006","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pmic.200600756","article-title":"A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry","volume":"7","author":"Pan","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0195","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1021\/pr060251s","article-title":"Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach","volume":"5","author":"Pan","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/pr070501k","article-title":"Integrated analysis of the cerebrospinal fluid peptidome and proteome","volume":"7","author":"Zougman","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nbt1183","article-title":"Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study","volume":"24","author":"States","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0210","doi-asserted-by":"crossref","first-page":"e10980","DOI":"10.1371\/journal.pone.0010980","article-title":"Establishing the proteome of normal human cerebrospinal fluid","volume":"5","author":"Schutzer","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jprot.2010.11.010_bb0215","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1074\/mcp.M600068-MCP200","article-title":"High dynamic range characterization of the trauma patient plasma proteome","volume":"5","author":"Liu","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0220","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/pmic.200401245","article-title":"HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples","volume":"5","author":"Rai","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0225","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/prca.200700243","article-title":"Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers","volume":"1","author":"Meng","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2010.11.010_bb0230","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1002\/pmic.200401226","article-title":"Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project","volume":"5","author":"Li","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0235","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/pmic.200500358","article-title":"Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database","volume":"5","author":"Omenn","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0240","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1074\/mcp.M200066-MCP200","article-title":"Toward a human blood serum proteome\u2014analysis by multidimensional separation coupled with mass spectrometry","volume":"1","author":"Adkins","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/CP:1:2:101","article-title":"Analysis of the human serum proteome","volume":"1","author":"Chan","year":"2004","journal-title":"Clin Proteomics J"},{"key":"10.1016\/j.jprot.2010.11.010_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1074\/mcp.T400006-MCP200","article-title":"The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data","volume":"3","author":"Carr","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid","volume":"310","author":"Reiber","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jprot.2010.11.010_bb0265","first-page":"199","article-title":"Species-dependent variables in blood cerebrospinal fluid barrier for proteins","volume":"21","author":"Reiber","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0270","first-page":"R20","article-title":"Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging","volume":"262","author":"Nilsson","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0275","series-title":"CSF flow\u2014its influence on CSF concentraion of brain-derived and blood-derived proteins. New York","author":"Reiber","year":"1997"},{"key":"10.1016\/j.jprot.2010.11.010_bb0280","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jprot.2010.11.010_bb0285","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000116918","article-title":"Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid\/serum albumin ratio","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0290","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1021\/pr060251s","article-title":"Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach","volume":"5","author":"Pan","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2005-8407","article-title":"Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases","volume":"8","author":"Zhang","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2005.12.028","article-title":"Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat","volume":"79","author":"Murillo-Rodriguez","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0305","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/prca.200700380","article-title":"Impact of preanalytical variables on the analysis of biological fluids in proteomic studies","volume":"1","author":"Ferguson","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2010.11.010_bb0310","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1373\/clinchem.2005.058776","article-title":"Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides","volume":"52","author":"Lewczuk","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0315","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1007516210548","article-title":"Measurement of apolipoprotein E (apoE) in cerebrospinal fluid","volume":"25","author":"Hesse","year":"2000","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0320","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/pr900095u","article-title":"Peptide storage: are you getting the best return on your investment? Defining optimal storage conditions for proteomics samples","volume":"8","author":"Kraut","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/NCC:4:2:153","article-title":"Spectrophotometry for cerebrospinal fluid pigment analysis","volume":"4","author":"Petzold","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jprot.2010.11.010_bb0330","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/prca.200700126","article-title":"Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome","volume":"1","author":"Berven","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2010.11.010_bb0335","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/prca.200700330","article-title":"Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables","volume":"1","author":"Jimenez","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2010.11.010_bb0340","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pmic.200400889","article-title":"The impact of blood contamination on the proteome of cerebrospinal fluid","volume":"5","author":"You","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0345","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/pmic.200402039","article-title":"Truncated cystatin C in cerebrospiral fluid: Technical artefact or biological process?","volume":"5","author":"Carrette","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1385\/CP:2:1:91","article-title":"Assessment of protein stability in cerebrospinal fluid using surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry protein profiling","volume":"2","author":"Ranganathan","year":"2006","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0355","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/pr9005876","article-title":"The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF)","volume":"8","author":"Rosenling","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0360","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/sj.npp.1300231","article-title":"Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism","volume":"28","author":"Sher","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jprot.2010.11.010_bb0365","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/appi.ajp.160.4.773","article-title":"Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders","volume":"160","author":"Malone","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jprot.2010.11.010_bb0370","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/pmic.200700455","article-title":"Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion","volume":"7","author":"Ogata","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0375","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1074\/mcp.M500207-MCP200","article-title":"Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid","volume":"4","author":"Hu","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0380","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome\u2014history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0385","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jchromb.2010.04.003","article-title":"Assessment of the partitioning capacity of high abundant proteins in human cerebrospinal fluid using affinity and immunoaffinity subtraction spin columns","volume":"878","author":"Wetterhall","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/BA20080015","article-title":"Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid","volume":"52","author":"Ramstr\u00f6m","year":"2009","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85686","article-title":"Large-scale analysis of the yeast proteome by multidimensional protein identification technology","volume":"19","author":"Washburn","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0400","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1074\/mcp.M300087-MCP200","article-title":"Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry","volume":"2","author":"Schirle","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mas.20221","article-title":"Glycoproteomics in neurodegenerative diseases","volume":"29","author":"Hwang","year":"2010","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.jprot.2010.11.010_bb0410","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/S0021-9258(19)41496-8","article-title":"High resolution two-dimensional electrophoresis of proteins","volume":"250","author":"O'Farrell","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0415","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-60761-157-8_4","article-title":"Protein detection and quantitation technologies for gel-based proteome analysis","volume":"564","author":"Weiss","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1570-0232(02)00043-0","article-title":"Detection technologies in proteome analysis","volume":"771","author":"Patton","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/epr.09.99","article-title":"2D DIGE of the cerebrospinal fluid proteome in neurological diseases","volume":"7","author":"Tumani","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0430","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/elps.1150181133","article-title":"Difference gel electrophoresis: a single gel method for detecting changes in protein extracts","volume":"18","author":"Unlu","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0435","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/(SICI)1522-2683(20000401)21:6<1071::AID-ELPS1071>3.0.CO;2-M","article-title":"Proteomics: capacity versus utility","volume":"21","author":"Harry","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbpa.2006.01.008","article-title":"The amplified peptidome: the new treasure chest of candidate biomarkers","volume":"10","author":"Geho","year":"2006","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0445","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1515\/CCLM.2007.351","article-title":"Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations","volume":"45","author":"Kiehntopf","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jprot.2010.11.010_bb0450","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1155\/2001\/674959","article-title":"Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer","volume":"17","author":"Paweletz","year":"2001","journal-title":"Dis Markers"},{"key":"10.1016\/j.jprot.2010.11.010_bb0455","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2011","article-title":"The blood peptidome: a higher dimension of information content for cancer biomarker discovery","volume":"6","author":"Petricoin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jprot.2010.11.010_bb0460","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.copbio.2004.01.005","article-title":"SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer","volume":"15","author":"Petricoin","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0465","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.mp.4002108","article-title":"Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues","volume":"13","author":"Huang","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jprot.2010.11.010_bb0470","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000080991","article-title":"Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology","volume":"1","author":"Maddalena","year":"2004","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2010.06.017","article-title":"Proteomic investigations of the ventriculo-lumbar gradient in human CSF","author":"Simonsen","year":"2010","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jprot.2010.11.010_bb0480","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/pr025517j","article-title":"Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry","volume":"1","author":"Chelius","year":"2002","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0485","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/ac0498563","article-title":"A model for random sampling and estimation of relative protein abundance in shotgun proteomics","volume":"76","author":"Liu","year":"2004","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0490","doi-asserted-by":"crossref","first-page":"840518","DOI":"10.1155\/2010\/840518","article-title":"Mass spectrometry-based label-free quantitative proteomics","volume":"2010","author":"Zhu","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0495","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0500","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1074\/mcp.M600222-MCP200","article-title":"PEPPeR, a platform for experimental proteomic pattern recognition","volume":"5","author":"Jaffe","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0505","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/ac0493875","article-title":"Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures","volume":"76","author":"Wiener","year":"2004","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0510","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1074\/mcp.M800218-MCP200","article-title":"Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification","volume":"7","author":"Jaffe","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0515","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/pr900925d","article-title":"Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry","volume":"9","author":"Paweletz","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0520","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","article-title":"Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents","volume":"3","author":"Ross","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0525","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ac0262560","article-title":"Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS","volume":"75","author":"Thompson","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0530","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","article-title":"Quantitative analysis of complex protein mixtures using isotope-coded affinity tags","volume":"17","author":"Gygi","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0535","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/pmic.200400873","article-title":"A novel strategy for quantitative proteomics using isotope-coded protein labels","volume":"5","author":"Schmidt","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0540","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1002\/pmic.200800297","article-title":"Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates","volume":"8","author":"Boersema","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0545","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14789450.5.6.761","article-title":"Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?","volume":"5","author":"Issaq","year":"2008","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0550","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0555","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/epr.09.11","article-title":"Preparing multiple-reaction monitoring for quantitative clinical proteomics","volume":"6","author":"Kim","year":"2009","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0560","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nbt.1546","article-title":"Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma","volume":"27","author":"Addona","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0565","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M700354-MCP200","article-title":"Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution","volume":"6","author":"Keshishian","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0570","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1074\/mcp.M900140-MCP200","article-title":"Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution","volume":"8","author":"Keshishian","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0575","doi-asserted-by":"crossref","DOI":"10.1039\/c0an00105h","article-title":"Mass-spectrometry-based clinical proteomics\u2014a review and prospective","author":"Parker","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.jprot.2010.11.010_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2010.04.020","article-title":"Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach","author":"van Dijk","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2007.00985.x","article-title":"Clinical proteomics in neurodegenerative disorders","volume":"118","author":"Zetterberg","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jprot.2010.11.010_bb0590","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2741\/3341","article-title":"Proteomics\/peptidomics tools to find CSF biomarkers for neurodegenerative diseases","volume":"14","author":"Westman-Brinkmalm","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0595","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2008.09.004","article-title":"Biomarker discovery in neurodegenerative diseases: a proteomic approach","volume":"35","author":"Shi","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0600","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/138920106777549713","article-title":"Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis","volume":"7","author":"Berven","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0605","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/awh176","article-title":"Development of biomarkers in multiple sclerosis","volume":"127","author":"Bielekova","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jprot.2010.11.010_bb0610","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","article-title":"Multiple sclerosis cerebrospinal fluid biomarkers","volume":"22","author":"Giovannoni","year":"2006","journal-title":"Dis Markers"},{"key":"10.1016\/j.jprot.2010.11.010_bb0615","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03256329","article-title":"Disease biomarkers in multiple sclerosis potential for use in therapeutic decision making","volume":"13","author":"Harris","year":"2009","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jprot.2010.11.010_bb0620","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/092986707781368478","article-title":"Biological markers for multiple sclerosis","volume":"14","author":"Lutterotti","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0625","doi-asserted-by":"crossref","first-page":"37061","DOI":"10.1074\/jbc.M403672200","article-title":"Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection","volume":"279","author":"Liao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0630","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2008.10.003","article-title":"Biomarkers of Alzheimer's disease","volume":"35","author":"Craig-Schapiro","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0635","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2009.06558.x","article-title":"An update on clinical proteomics in Alzheimer's research","volume":"112","author":"Korolainen","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2007.00985.x","article-title":"Clinical proteomics in neurodegenerative disorders","volume":"118","author":"Zetterberg","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jprot.2010.11.010_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2008.07.003","article-title":"Proteomics in animal models of Alzheimer's and Parkinson's diseases","volume":"8","author":"Sowell","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jprot.2010.11.010_bb0650","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jprot.2010.11.010_bb0655","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jprot.2010.11.010_bb0660","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"343","author":"Jacobs","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jprot.2010.11.010_bb0665","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2010.11.010_bb0670","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.1997.tb08144.x","article-title":"Viruses and multiple sclerosis","volume":"95","author":"Dalgleish","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jprot.2010.11.010_bb0675","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(96)90807-7","article-title":"Evidence for genetic basis of multiple sclerosis","volume":"347","author":"Sadovnick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2010.11.010_bb0680","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2008.01026.x","article-title":"Diagnosis and treatment of multiple sclerosis","volume":"117","author":"Myhr","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jprot.2010.11.010_bb0685","first-page":"57","article-title":"Multiple sclerosis: it's not the disease you thought it was","volume":"1","author":"Loren","year":"2002","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0690","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Medical progress: multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jprot.2010.11.010_bb0695","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0700","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 Revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0705","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/brain\/113.5.1269","article-title":"A study of immunoglobulin-G in the cerebrospinal-fluid of 1007 patients with suspected neurological disease using isoelectric-focusing and the log Igg-index\u2014a comparison and diagnostic applications","volume":"113","author":"Mclean","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.jprot.2010.11.010_bb0710","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","article-title":"Proteomic analysis of multiple sclerosis cerebrospinal fluid","volume":"10","author":"Hammack","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jprot.2010.11.010_bb0715","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/pmic.200300715","article-title":"Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients","volume":"4","author":"Dumont","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0720","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1468-1331.2008.02239.x","article-title":"CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis","volume":"15","author":"Chiasserini","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0725","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jprot.2010.01.004","article-title":"Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers","volume":"73","author":"Ottervald","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0730","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1352458507076406","article-title":"Cerebrospinal fluid proteome profile in multiple sclerosis","volume":"13","author":"Lehmensiek","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jprot.2010.11.010_bb0735","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10571-008-9312-z","article-title":"Alteration of DBP levels in CSF of patients with MS by proteomics analysis","volume":"29","author":"Qin","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0740","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2009.01.057","article-title":"CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis","volume":"452","author":"Tumani","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jprot.2010.11.010_bb0745","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/j.1471-4159.2007.04985.x","article-title":"Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis","volume":"103","author":"Mattsson","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.jprot.2010.11.010_bb0750","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1021\/pr0504788","article-title":"Lumbar cerebrospinal fluid proteome in multiple sclerosis: Characterization by ultrafiltration, liquid chromatography, and mass spectrometry","volume":"5","author":"Noben","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0755","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/pmic.200700446","article-title":"Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry","volume":"8","author":"Stoop","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2010.11.010_bb0760","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","author":"Comabella","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jprot.2010.11.010_bb0765","doi-asserted-by":"crossref","DOI":"10.1021\/pr8010155","article-title":"Quantitative matrix-assisted laser desorption ionization-Fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins","author":"Stoop","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0770","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/pr070012k","article-title":"Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord","volume":"6","author":"Liu","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0775","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-5956-7-25","article-title":"Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord","volume":"7","author":"Jain","year":"2009","journal-title":"Proteome Sci"},{"key":"10.1016\/j.jprot.2010.11.010_bb0780","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","article-title":"Alzheimer's disease: cell-specific pathology isolates the hippocampal formation","volume":"225","author":"Hyman","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jprot.2010.11.010_bb0785","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2010.11.010_bb0790","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0795","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/bmm.09.65","article-title":"Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications","volume":"3","author":"Mattsson","year":"2009","journal-title":"Biomark Med"},{"key":"10.1016\/j.jprot.2010.11.010_bb0800","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-009-0502-7","article-title":"The role of proteomics in dementia and Alzheimer's disease","volume":"118","author":"Zellner","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0805","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arr.2009.04.002","article-title":"Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment","volume":"8","author":"Mangialasche","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jprot.2010.11.010_bb0810","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2009.09.008","article-title":"Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects","volume":"45","author":"Cedazo-Minguez","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0815","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archneur.64.3.366","article-title":"Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment","volume":"64","author":"Simonsen","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0820","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neurobiolaging.2007.01.011","article-title":"Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease","volume":"29","author":"Simonsen","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jprot.2010.11.010_bb0825","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00001756-200204160-00015","article-title":"Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients","volume":"13","author":"Davidsson","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.jprot.2010.11.010_bb0830","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","article-title":"Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease","volume":"118","author":"Puchades","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0835","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.21038","article-title":"Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease","volume":"61","author":"Finehout","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0840","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2009.01.058","article-title":"Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases","volume":"1265","author":"Yin","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0845","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson's disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0850","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jprot.2010.11.010_bb0855","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jprot.2010.11.010_bb0860","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jprot.2010.11.010_bb0865","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jprot.2010.11.010_bb0870","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jprot.2010.11.010_bb0875","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.wco.0000168241.53853.32","article-title":"The role of alpha-synuclein and tau in neurodegenerative movement disorders","volume":"18","author":"Wenning","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jprot.2010.11.010_bb0880","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/cr.2009.131","article-title":"Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0885","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1155\/2005\/806573","article-title":"Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease","volume":"21","author":"Finehout","year":"2005","journal-title":"Dis Markers"},{"key":"10.1016\/j.jprot.2010.11.010_bb0890","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2008.09.026","article-title":"Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach","volume":"400","author":"Sinha","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jprot.2010.11.010_bb0895","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/jnr.21452","article-title":"Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration","volume":"85","author":"Rite","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jprot.2010.11.010_bb0900","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jprot.2010.11.010_bb0905","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/pr700630x","article-title":"Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption\/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF\/TOF) platform","volume":"7","author":"Pan","year":"2008","journal-title":"J Proteome Res"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391910003210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391910003210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T05:41:08Z","timestamp":1636868468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391910003210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":181,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1874391910003210"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2010.11.010","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}